Tower Wealth Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
VCM
VPM
Tower Wealth Partners's AMGN Position: Q1 2026 in Review
Tower Wealth Partners increased its Amgen (AMGN) stake by 13% in Q1 2026, buying an estimated $51.7K and bringing the position to 1,254 shares worth $441K. The position accounts for 0.24% of the portfolio, ranked #51.
Tower Wealth Partners first reported a position in AMGN in Q4 2022 and has held it in 10 quarters since. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Tower Wealth Partners held 1,254 shares of Amgen worth $441K as of Q1 2026.
- Tower Wealth Partners bought 145 Amgen shares in Q1 2026, an estimated $51.7K.
- Amgen made up 0.24% of Tower Wealth Partners's portfolio in Q1 2026, its #51 holding.
- Tower Wealth Partners first reported a position in Amgen in Q4 2022 and has held it in 10 quarters since.
- 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Tower Wealth Partners's 13F filing for Q1 2026, filed 8 May 2026.